Topics
Meningioma | Treatment | Clinical trials | Sintilimab
Home > Publications > Topics > Meningioma > Treatment > Clinical trials > Sintilimab
Wang Y, Wang C, Yin S, Yu C, Li X, Kang X, Yang S, Xie W, Lin Y,
Wu Z, Li W, Chen F.
Phase 2 Trial of
PD-1 Inhibitor Sintilimab in Recurrent/Progressive Meningioma.
CNS
Neurosci Ther. 2025 Dec 8;31(12):e70659. doi:
10.1111/cns.70659. PMID:
41358608. Interventional study. ˍ